Fusion Pharmaceuticals
targeted alpha therapy tats as next generation antibody drug conjugates | Fusion Pharmaceuticals
Deck date
August 2023
Slide
32 of 33
Similar slides by Fusion Pharmaceuticals
Investor Presentation
November 2023
Other recent decks by Fusion Pharmaceuticals
Investor Presentation
January 2024
Investor Presentation
November 2023
IPO
June 2020
Search Thousands of Presentations by World Leading Companies